Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
SCIESSENT LLC	BEVERLY MA

International Classification(s)

• A01N:PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLA....
• A23L:FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT....

• 2015 Application Filing Year
• A01N Class
• 1937 Applications Filed
• 1429 Patents Issued To-Date
• 73.78 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Crudden, Joseph J	Hudson, US	39	341
# of filed Patents : 39 Total Citations : 341

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A01N Class

• 0 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jul 26, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
January 26, 2016	US,9241492,B2   US9241492B2	GRANTED PATENT AS SECOND PUBLICATION
September 03, 2015	US,20150245619,A1   US20150245619A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent Application No: 2016/0153,983

BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS

---

Abstract

---

The present invention relates to peptides biomarkers that are specifically recognized by autoantibodies present in the sera of patients with Rheumatoid Arthritis (RA). More specifically, the invention provides epitopes of PAD4, of BRAF, and of calpastatin as well as methods and kits for using these sequences for the diagnosis of RA, in particular for the diagnosis of RA in CCP-negative subjects.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.